Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001570562-26-000020
Filing Date
2026-02-19
Accepted
2026-02-19 20:57:12
Documents
1
Period of Report
2026-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1771552629.html 4  
1 FORM 4 wk-form4_1771552629.xml 4 3564
  Complete submission text file 0001570562-26-000020.txt   5049
Mailing Address C/O EVOLUS, INC. 520 NEWPORT CENTER DR., SUITE 1200 NEWPORT BEACH CA 01843
Business Address
GILL DAVID N (Reporting) CIK: 0001106519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38381 | Film No.: 26656461

Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Issuer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)